FENNEC PHARMACEUTICALS INC.
Company Stats
- Market Cap
- $373.5M
- as of Sep 30, 2026
- Shares Outstanding
- 35.1M
- Free Float
- 80.2%
Income Statement
- Revenue
- $44.6M
- Operating Income
- -$6.3M
- Net Income
- -$9.7M
Balance Sheet
- Cash & Equivalents
- $36.8M
Returns & Capital
- SBC, 3Y Avg
- $5.8M
Cash Flow by Year
| Year | Revenue | FCF | Margin |
|---|---|---|---|
| FY2025 | $44.6M | — | — |
| FY2024 | $47.5M | — | — |
| FY2023 | $23.8M | — | — |
| FY2022 | $1.8M | -$18.2M | -1030.7% |
Annual filing data through FY ended December 31, 2025; shares and float as of October 28, 2026. Yields and enterprise value use the calculated market cap above, at its as-of date. Ratios are our calculations from reported figures.
Companies Report Firm Demand, Relentless Cost Pressure